La directrice médicale d’Enliven Therapeutics cède des actions pour 251.000$
Read the full article on Investing.com →KioskNews shows the publisher’s own headline, image, and summary — the full article always lives on their site, not ours.
Read the full article on Investing.com →KioskNews shows the publisher’s own headline, image, and summary — the full article always lives on their site, not ours.
Pick a conversation — tap 💬 on any story